The current valuation score of Xeris Biopharma Holdings Inc is 9.84, ranking 7 out of 158 in the Pharmaceuticals industry. Its current P/E ratio is 114.89, which is 1507.08% below the recent high of 1846.38 and 171.23% above the recent low of -81.84.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.